Table 1.
Cyclooxygenase inhibitors in acute brain injury
| Sl. No | Compound | Species | Injury | Effect | Ref |
|---|---|---|---|---|---|
| 1 | Ibuprofen | Mice | TBI, Fluid percussion | No effect | (Harrison et al., 2014) |
| 2 | Indomethacin | Rats | TBI, Fluid percussion | Reduced mortality due to more rapid return to normal breathing after the apneic period post-TBI. | (Kim et al., 1989) |
| 3 | Nimesulide | Rat | TBI, impact acceleration diffuse TBI | Substantial improvement in cognitive function | (Cernak et al., 2002) |
| 4 | Meloxicam | Rat | TBI, Mild weight drop | Reduced MDA, cerebral edema, blood brain barrier (BBB) permeability, restored glutathione levels, improved neurological score at 48h. | (Hakan et al., 2010) |
| 5 | Indomethacin | Mice | TBI, Weight drop | Reduction in brain 6-Keto PGF1α levels (6 h) and neurodeficit, no effect on brain edema | (Girgis et al., 2013) |
| 6 | Carpofen | Mice | TBI, Weight Drop | Reduced lesion size; water content and number of microglia in the lesioned cortex; lowered the levels of proinflammatory cytokines and improved functional outcome | (Thau-Zuchman et al., 2012) |
| 7 | Celecoxib | Rat | TBI, Weight drop | No effect on the neurological score or the brain water content | (Girgis et al., 2013) |
| 8 | Meloxicam | Mice | TBI, Weight drop | No effect on the neurological score or the brain water content | (Girgis et al., 2013) |
| 9 | Lornoxicam | Rats | TBI, weight drop diffuse TBI | Reduced brain edema but did not affect BBB permeability | (Topcu et al., 2013) |
| 10 | Nimesulide | Rat | Trauma, Impact acceleration | Improved memory (Barnes maze) and motor (rotarod) performance after neurotrauma | (Cernak et al., 2001) |
| 11 | Roficoxib | Rat | TBI, FPI | No effect on hippocampal neuronal death | (Kunz et al., 2006) |
| 12 | Indomethacin | Human | TBI, Head-injured patients | Decreased ICP as well as cerebral blood flow and temperature | (Jensen et al., 1991) |